Status:
COMPLETED
Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The overall objective of the study is to assess the feasibility of the use of blood for the detection of EGFR mutations in patients with non-small cell lung cancer (NSCLC) Specific aims are: 1. To a...
Detailed Description
The oral tyrosine kinase (TK) inhibitors of Epidermal Growth Factor Receptor (EGFR), gefitinib and erlotinib, have produced dramatic responses, encouraging response rates and possibly improved surviva...
Eligibility Criteria
Inclusion
- Patients with non small cell lung cancer.
Exclusion
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
End Date :
April 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00717002
Start Date
February 1 2008
End Date
April 1 2013
Last Update
December 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore